Literature DB >> 8024255

Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.

W I McDonald1, D H Miller, A J Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8024255     DOI： 10.1002/ana.410360106

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  8 in total

Review 1.  More immunotherapy for multiple sclerosis.

Authors:  R A Hughes; B Sharrack
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

Review 2.  Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

Authors:  M Filippi; M Rovaris; G Comi
Journal:  Ital J Neurol Sci       Date:  1996-12

3.  MRI dynamics of brain and spinal cord in progressive multiple sclerosis.

Authors:  D Kidd; J W Thorpe; B E Kendall; G J Barker; D H Miller; W I McDonald; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

4.  Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.

Authors:  C Liu; S Edwards; Q Gong; N Roberts; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

5.  Neuroanatomy of pseudobulbar affect : a quantitative MRI study in multiple sclerosis.

Authors:  Omar Ghaffar; Laury Chamelian; Anthony Feinstein
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

6.  Multi-parametric MR assessment of T(1) black holes in multiple sclerosis : evidence that myelin loss is not greater in hypointense versus isointense T(1) lesions.

Authors:  I M Vavasour; D K B Li; C Laule; A L Traboulsee; G R W Moore; A L Mackay
Journal:  J Neurol       Date:  2007-11-12       Impact factor: 4.849

Review 7.  Mind the gap: from neurons to networks to outcomes in multiple sclerosis.

Authors:  Declan T Chard; Adnan A S Alahmadi; Bertrand Audoin; Thalis Charalambous; Christian Enzinger; Hanneke E Hulst; Maria A Rocca; Àlex Rovira; Jaume Sastre-Garriga; Menno M Schoonheim; Betty Tijms; Carmen Tur; Claudia A M Gandini Wheeler-Kingshott; Alle Meije Wink; Olga Ciccarelli; Frederik Barkhof
Journal:  Nat Rev Neurol       Date:  2021-01-12       Impact factor: 42.937

Review 8.  Outcome Measures in Clinical Trials for Multiple Sclerosis.

Authors:  Caspar E P van Munster; Bernard M J Uitdehaag
Journal:  CNS Drugs       Date:  2017-03       Impact factor: 5.749
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.